J.H. Whitney Equity Partners V Sells 919,389 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 919,389 shares of the business’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total transaction of $7,355,112.00. Following the sale, the insider owned 12,531,158 shares in the company, valued at $100,249,264. This trade represents a 6.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Trading Up 1.9%

Shares of AVAH stock opened at $8.64 on Friday. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The stock has a market capitalization of $1.88 billion, a P/E ratio of 7.32, a price-to-earnings-growth ratio of 0.89 and a beta of 1.93. The company has a 50 day moving average price of $7.14 and a 200 day moving average price of $7.58. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.73 and a fifty-two week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm’s revenue was up 15.9% on a year-over-year basis. Equities research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price objective on the stock in a research report on Friday, March 20th. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Weiss Ratings downgraded Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. BMO Capital Markets cut their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Finally, Truist Financial increased their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.50.

Institutional Investors Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Dynamic Technology Lab Private Ltd lifted its stake in Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after purchasing an additional 1,151 shares during the last quarter. Barclays PLC increased its stake in Aveanna Healthcare by 0.8% in the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after purchasing an additional 1,366 shares during the last quarter. Franklin Resources Inc. increased its stake in Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after purchasing an additional 1,528 shares during the last quarter. Intech Investment Management LLC raised its holdings in Aveanna Healthcare by 9.8% during the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after purchasing an additional 1,739 shares in the last quarter. Finally, Balboa Wealth Partners raised its holdings in Aveanna Healthcare by 13.5% during the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock worth $138,000 after purchasing an additional 2,007 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.